Reactivation of hepatitis virus B infection in a patient with rheumatoid arthritis after treatment with rituximab

Reumatol Clin. 2014 May-Jun;10(3):196-7. doi: 10.1016/j.reuma.2013.05.011. Epub 2013 Sep 17.

[Article in English, Spanish]

Authors

Tarek Carlos Salman-Monte¹, María Pilar Lisbona², Montserrat García-Retortillo³, Joan Maymó²

Affiliations

¹ Servicio de Reumatología, Parc de Salut Mar, Hospital del Mar, IMIM, Universidad Autónoma de Barcelona, Barcelona, España. Electronic address: tareto4@gmail.com.
² Servicio de Reumatología, Parc de Salut Mar, Hospital del Mar, IMIM, Universidad Autónoma de Barcelona, Barcelona, España.
³ Sección de Hepatología, Parc de Salut Mar, Hospital del Mar, IMIM, Universidad Autónoma de Barcelona, Barcelona, España.

PMID: 24054835
DOI: 10.1016/j.reuma.2013.05.011

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Murine-Derived / adverse effects*
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antirheumatic Agents / adverse effects*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / drug therapy
Hepatitis B / chemically induced*
Hepatitis B virus / drug effects*
Hepatitis B virus / physiology*
Humans
Male
Rituximab
Virus Replication / drug effects*

Substances

Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents
Rituximab